Advancing precision medicine

Webinar title: "Advancing precision medicine: Prognostic biomarkers for pediatric Crohn's disease"

In this webinar, Dr. Andres Hurtado-Lorenzo presents findings from a Crohn's & Colitis Foundation study to identify predictive biomarkers related to both prognosis of complications and therapy response outcomes in pediatric Crohn's disease.

Watch the webinar to learn more about:

  • Their use of data from multiomics studies, such as RNAseq and plasma proteomics, to develop a high performance, prognostic protein signature for Crohn's complications.
  • How they used Olink and machine learning to develop a prognostic protein panel to predict development of fibrosis with an accuracy of 84%, and a 3-protein signature that predicts response to anti-TNF therapy with an accuracy of 90%.
  • Development of a custom panel which as been further tested and verified as an effective tool for future management of Crohn's disease.



Dr. Andres Hurtado-Lorenzo

VP Translational Research at the Crohn's and Colitis Foundation

Watch the recording now!